단순방광염의 경험치료제의 선택: 더 이상 가능하지 않은 무임승차
The Choice of Empirical Treatment of Uncomplicated Cystitis: No Longer Free Ride
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Resistance of uropathogenic E. coli to trimethoprim/sulfamethoxazole in Korea has surpassed the threshold of 20% at which the drug is no longer recommended for empirical treatment and routine urine culture is recommended. Given the unavailability of alternative agents other than fluoroquinolones, increased use of this agent, which is known to cause collateral damage, appears inevitable. However,the majority of study data have been reported from studies of pyelonephritis, and seldom represent the level of resistance of community acquired uncomplicated cystitis. For selection of a rational empirical agent according to the guidelines, judicious interpretation of recent studies conducted in Korea with regard to quality of the evidence is required.
Abstract
Resistance of uropathogenic E. coli to trimethoprim/sulfamethoxazole in Korea has surpassed the threshold of 20% at which the drug is no longer recommended for empirical treatment and routine urine culture is recommended. Given the unavailability of alternative agents other than fluoroquinolones, increased use of this agent, which is known to cause collateral damage, appears inevitable. However,the majority of study data have been reported from studies of pyelonephritis, and seldom represent the level of resistance of community acquired uncomplicated cystitis. For selection of a rational empirical agent according to the guidelines, judicious interpretation of recent studies conducted in Korea with regard to quality of the evidence is required.
참고문헌 (25)
- 대한감염학회, "요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염", Infection and Chemotherapy, 43(1), pp.1~25 (2011), 대한감염학회
- Raz R., "Empiric use of trimethoprim-sulfamethoxazole(TMP-SMX)in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens", Clin Infect Dis, 34, pp.1165~1169 (2002)
- Warren JW., "Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America(IDSA)", Clin Infect Dis, 29, pp.745~758 (1999)
- Tollman SM., "What are the effects of the fifth revision of the Declaration of Helsinki?", BMJ, 323, pp.1417~1423 (2001)
- Ferry SA., "The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study", Scand J Infect Dis, 36, pp.296~301 (2004)
- Gupta K., "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases", Clin Infect Dis, 52, pp.e103~e120 (2011)
- Paterson DL., ""Collateral damage" from cephalosporin or quinolone antibiotic therapy", Clin Infect Dis, 38(Suppl 4), pp.S341~S345 (2004)
- 이꽃실, "요로감염증에 대한 Piperacillin", sulbactam (Combicin？)의 치료효과 및 안전성 : 제 3상 임상연구, 2002, pp.34(4), 235~241[DOI]
- Wie SH., "Antibiotic sensitivity of the causative organisms and use of antibiotics in women with community-acquired acute pyelonephritis", Korean J Infect Dis, 34, pp.353~359 (2002)
- Wie SH., "Clinical features and antimicrobial resistance among clinical isolates of women with community-acquired acute pyelonephritis in 2001-2006", Infect Chemother, 39, pp.9~16 (2007)
- 유광호, "최근 요로감염증의 주요 원인균과 항생제 감수성에 관한 고찰", Korean Journal of Urology, 48(6), pp.638~645 (2007), 대한비뇨기과학회
- Lee SJ., "Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002", Int J Antimicrob Agents, 24(Suppl 1), pp.S61~S64 (2004)
- Kim ME., "Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006", Int J Antimicrob Agents, 31(Suppl 1), pp.S15~S18 (2008)
- 손동완, "외래 방문 여성 급성 단순성 방광염 환자에서 분리된 Escherichia coli에 대한 경구 항생제의 시험관 내 감수성 연구", Infection and Chemotherapy, 38(3), pp.140~145 (2006), 대한감염학회
- 김봉영, "국내에서 지역사회 급성 신우신염 원인균의 항균제 감수성 결과에 근거하여 지역사회 급성 방광염 치료 항균제를 선택할 수 있는가?", Infection and Chemotherapy, 44(4), pp.269~274 (2012), 대한감염학회
- Czaja CA., "Populationbased epidemiologic analysis of acute pyelonephritis", Clin Infect Dis, 45, pp.273~280 (2007)
- Scholes D., "Risk factors associated with acute pyelonephritis in healthy women", Ann Intern Med, 142, pp.20~27 (2005)
- Jeon JH., "Empirical Use of Ciprofloxacin for Acute Uncomplicated Pyelonephritis Caused by Escherichia coli in Communities Where the Prevalence of Fluoroquinolone Resistance Is High", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 56(6), pp.3043~3046 (2012), AMER SOC MICROBIOLOGY
- 임승관, "Change of Antimicrobial Susceptibility among Escherichia coli Strains Isolated from Female Patients with Community-Onset Acute Pyelonephritis", Yonsei Medical Journal, 53(1), pp.164~171 (2012), 연세대학교의과대학
- Pépin J., "Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea : a cohort study during an epidemic in Quebec", Clin Infect Dis, 41, pp.1254~1260 (2005)
- 배현주, "Clostridium difficile 감염의 역학 및 치료", Infection and Chemotherapy, 42(6), pp.362~368 (2010), 대한감염학회
- Weiss K., "Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec", Clin Infect Dis, 42, pp.725~727 (2006)
- Vila J., "Are quinolone-resistant uropathogenic Escherichia coli less virulent?", J Infect Dis, 186, pp.1039~1042 (2002)
- 김경영, "최근 2년간 전라남도 및 광주지역의 지역사회 획득성 요로감염에 이환된 여성 환자에서 동정된 Escherichia coli의 Ciprofloxacin 내성패턴", Korean Journal of Urology, 49(6), pp.540~548 (2008), 대한비뇨기과학회
- 황병연, "서울 강서지역 1개 대학병원에서 성인 급성 신우신염의 원인균과 항생제 감수성", Infection and Chemotherapy, 35(5), pp.277~282 (2003), 대한감염학회